Literature DB >> 2156837

Purification of branched chain aminotransferase from rat heart mitochondria.

R Wallin1, T R Hall, S M Hutson.   

Abstract

This paper presents the first purification of the branched chain aminotransferase (EC 2.6.1.42) from rat heart mitochondria. The enzyme has been purified from the 100,000 x g supernatant obtained after sonication and ultracentrifugation of rat heart mitochondria. A combination of open column chromatography, high pressure liquid chromatography (HPLC), and discontinuous polyacrylamide disc gel electrophoresis was used. The key step in the procedure was hydrophobic interaction chromatography on HPLC. The final purification step was polyacrylamide disc gel electrophoresis where the enzyme appeared as a doublet. When electroeluted from the gel, each of these bands had the same specific activity demonstrating that there are two forms of the purified enzyme which differ slightly in electrical charge. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, these two enzyme forms appeared as a single band with a molecular mass of 43 kDa. Size exclusion chromatography on Sephacryl S-100 identified the enzyme as a 50-kDa protein. These experiments argue against the existence of a dimeric form of this enzyme. The ratio of enzyme activity with leucine (0.84), valine (0.88), or glutamate (0.66) as amino acid substrate versus isoleucine remained constant throughout the purification procedure. Specific activity of the final preparation was 66 units/mg of enzyme protein. Polyclonal antibodies against the purified enzyme were raised in rabbits. On an immunoblot the antiserum recognized a 43-kDa protein in the 100,000 x g supernatant from a rat heart mitochondrial sonicate but did not recognize any proteins in rat brain cytosol. Quantitative immunodot assay resulted in an estimated enzyme content of about 100 micrograms of branched chain aminotransferase protein/g of heart, wet weight. Finally, 97% of the heart branched chain aminotransferase activity could be neutralized by the antiserum, but the antiserum would not neutralize aminotransferase activity in brain cytosol. These data suggest that close sequence homology does not exist between the two proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Human branched-chain L-amino acid aminotransferase: Activity and subcellular localization in cultured skin fibroblasts.

Authors:  P Schadewaldt; U Wendel; H W Hammen
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

2.  Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells.

Authors:  Elitsa A Ananieva; Chirag H Patel; Charles H Drake; Jonathan D Powell; Susan M Hutson
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

3.  Aspartate aminotransferase and tylosin biosynthesis in Streptomyces fradiae.

Authors:  S H Lee; K J Lee
Journal:  Appl Environ Microbiol       Date:  1993-03       Impact factor: 4.792

4.  Glial metabolism of isoleucine.

Authors:  Radovan Murín; Ghasem Mohammadi; Dieter Leibfritz; Bernd Hamprecht
Journal:  Neurochem Res       Date:  2008-09-12       Impact factor: 3.996

Review 5.  Metabolic and regulatory roles of leucine in neural cells.

Authors:  Radovan Murín; Bernd Hamprecht
Journal:  Neurochem Res       Date:  2007-08-25       Impact factor: 3.996

6.  Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm).

Authors:  Mohammad Mainul Islam; Manisha Nautiyal; R Max Wynn; James A Mobley; David T Chuang; Susan M Hutson
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

7.  Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer.

Authors:  Sarra M Rahem; Nusrat J Epsi; Frederick D Coffman; Antonina Mitrofanova
Journal:  EBioMedicine       Date:  2020-10-21       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.